2019 media kitmmhimages.com/mkt/hc/mk/oncology_mk_2019_print.pdf2019 media kit 28k+ print...

11
CancerNetwork.com Last revised: 12/11/2018 and 2019 media kit PRACTICAL, PEER-REVIEWED PERSPECTIVES home of the journal ONCOLOGY

Upload: others

Post on 25-May-2020

4 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: 2019 media kitmmhimages.com/mkt/hc/mk/oncology_mk_2019_print.pdf2019 media kit 28K+ Print Circulation 8.00 Mins. Pages per Time on Site* 33.8K US E-News subscribers 161.4K Unique Visitors*

CancerNetwork.comLast revised: 12/11/2018and

2019 media kit

PRACTICAL, PEER-REVIEWED PERSPECTIVES

home of the journal ONCOLOGY

Page 2: 2019 media kitmmhimages.com/mkt/hc/mk/oncology_mk_2019_print.pdf2019 media kit 28K+ Print Circulation 8.00 Mins. Pages per Time on Site* 33.8K US E-News subscribers 161.4K Unique Visitors*

CancerNetwork.comLast revised: 12/11/2018and

ModernMedicine Network includes over 30 brands, spanning 17 markets to meet the marketing needs of the healthcare industry.

ModernMedicine Network reaches all sectors of the healthcare industry with tactical brands thru multiple touchpoints. We take pride in our creative approach to targeting qualified audiences, understanding those audiences and delivering relevant, practical content to decision makers. From custom solutions to standard display, our team optimizes the diversity and reach of the ModernMedicine Network to meet your expectations.

Engaging healthcare professionals with content that matters.

For more information on ModernMedicine brands and marketing materials go to ModernMedicine.com

1.25M+ database of HCPs

1.5M unique

visitors/month

3.5M average page views/month

780K print

subscribers

1000+ KOL’s on

Editorial board

Page 3: 2019 media kitmmhimages.com/mkt/hc/mk/oncology_mk_2019_print.pdf2019 media kit 28K+ Print Circulation 8.00 Mins. Pages per Time on Site* 33.8K US E-News subscribers 161.4K Unique Visitors*

CancerNetwork.comLast revised: 12/11/2018and

2019 media kit

28K+ Print

Circulation

8.00 Mins.

Time on Site*

33.8K US E-News subscribers

161.4K Unique Visitors*

321K Page views/

month*

1.7 Pages per

visit*

Get the latest insights from key opinion leaders in oncology, with articles, peer perspectives, video, podcasts, and interactive content that translates into clinical application for today’s practicing oncologist. Timely. Practical. Relevant.

www.cancernetwork.com

PRACTICAL, PEER-REVIEWED PERSPECTIVES SINCE 1987

OCTOBER 2018 | Vol 32 • No 10

How an Expert Approaches itProstate Cancer: When to Order an MRIAnnerleim Walton-Diaz, MD, Soroush Rais-Bahrami, MD

Genomics in PracticeEGFR-Mutated Lung CancerEmily Wynja, MSIV, Jenna Hove, BSN, Steven F. Powell, MD

Review ArticleImmunotherapy in Colorectal CancerCara Wilt, CRNP, Dung T. Le, MD

CAREY ANDERS ON

Dual HER2 Targeting in theAdjuvant Setting‘We must consider the financial toxicities’

OCTOBER 2018 VOL. 32 NO. 10

D

UA

L HE

R2

TAR

GE

TIN

G • H

ER

B-D

RU

G IN

TE

RA

CT

ION

S • P

SY

CH

OS

OC

IAL D

IST

RE

SS

• CD

K4

/6 IN

HIB

ITO

RS

C

AN

CE

RN

ET

WO

RK

.CO

M

PRACTICAL, PEER-REVIEWED PERSPECTIVES SINCE 1987

OCTOBER 2018 | Vol 32 • No 10

How an Expert Approaches itProstate Cancer: When to Order an MRIAnnerleim Walton-Diaz, MD, Soroush Rais-Bahrami, MD

Genomics in PracticeEGFR-Mutated Lung CancerEmily Wynja, MSIV, Jenna Hove, BSN, Steven F. Powell, MD

Review ArticleImmunotherapy in Colorectal CancerCara Wilt, CRNP, Dung T. Le, MD

CAREY ANDERS ON

Dual HER2 Targeting in theAdjuvant Setting‘We must consider the financial toxicities’

OCTOBER 2018 VOL. 32 NO. 10

D

UA

L HE

R2

TAR

GE

TIN

G • H

ER

B-D

RU

G IN

TE

RA

CT

ION

S • P

SY

CH

OS

OC

IAL D

IST

RE

SS

• CD

K4

/6 IN

HIB

ITO

RS

C

AN

CE

RN

ET

WO

RK

.CO

M

PRACTICAL, PEER-REVIEWED PERSPECTIVES

*Based on 6 month rolling average

NEW DESIGN to represent the new face of Oncology.

home of the journal ONCOLOGY

Page 4: 2019 media kitmmhimages.com/mkt/hc/mk/oncology_mk_2019_print.pdf2019 media kit 28K+ Print Circulation 8.00 Mins. Pages per Time on Site* 33.8K US E-News subscribers 161.4K Unique Visitors*

CancerNetwork.comLast revised: 12/11/2018and

print solutions

Trimming: Live matter: 6-1/2” x 4-1/2”Trim size: 7” x 5”Bleed size: 7-1/4” x 5-1/4”Cover tips jog to the bottom, glue along spine.Keep live matter 3/4” from trimmed edges from gutter trim.If client supplies, please provide at trim size 7” x 5”; 80# stock without attachments.

COVER TIPSGrab the reader’s attention with an exclusive Cover Tip, an effective way to enhance brand awareness, communicate timely information, or to lead the reader to additional content within the publication. Make a statement and be front of mind with your target audience. Only one cover tip per issue is available, contact your sales representative to take advantage of this powerful opportunity.

PRACTICAL, PEER-REVIEWED PERSPECTIVES SINCE 1987

OCTOBER 2018 | Vol 32 • No 10

How an Expert Approaches itProstate Cancer: When to Order an MRIAnnerleim Walton-Diaz, MD, Soroush Rais-Bahrami, MD

Genomics in PracticeEGFR-Mutated Lung CancerEmily Wynja, MSIV, Jenna Hove, BSN, Steven F. Powell, MD

Review ArticleImmunotherapy in Colorectal CancerCara Wilt, CRNP, Dung T. Le, MD

CAREY ANDERS ON

Dual HER2 Targeting in theAdjuvant Setting‘We must consider the financial toxicities’

OCTOBER 2018 VOL. 32 NO. 10

D

UA

L HE

R2

TAR

GE

TIN

G • H

ER

B-D

RU

G IN

TE

RA

CT

ION

S • P

SY

CH

OS

OC

IAL D

IST

RE

SS

• CD

K4

/6 IN

HIB

ITO

RS

C

AN

CE

RN

ET

WO

RK

.CO

M

Your Custom Message Here

Consult Sales Rep for availability and pricing.

OUTSERTS

Consult Sales Rep for availability and pricing.

Outserts are your opportunity to tell a rich story and engage the reader with a journey. This option focuses the reader’s attention and allows variable space to convey your message. Use Outserts to provide content that can be saved as a reference, or create a series to extend involvement from issue to issue. Outserts are polybagged, and available in a variety of size and options, contact your sales representative to explore this proven one to one marketing touchpoint.

Be seen first. Limited availability for this high impact position.

Page 5: 2019 media kitmmhimages.com/mkt/hc/mk/oncology_mk_2019_print.pdf2019 media kit 28K+ Print Circulation 8.00 Mins. Pages per Time on Site* 33.8K US E-News subscribers 161.4K Unique Visitors*

CancerNetwork.comLast revised: 12/11/2018and

print specifications and circulation

Trim: 7.75” x 5.40”

Bleed: 8” x 5.625”

1/2 Page Horizontal

Trim: 5” x 10.75”

Bleed: 5.25” x 11”

2/3 Page Vertical

Trim: 7.75” x 10.75”

Bleed: 8” x 11”

1 Page

Trim: 2.50” x 10.75”

Bleed: 2.75” x 11”

1/3 Page Vertical1/2 Page Vertical

Trim: 3.875” x 10.75”

Bleed: 4.125” x 11”

Additional SpecificationsLive matter: Hold 3/8” from trim on all sides.

Trim size of journal: 73/4” x 103/4” for final trim, 8” x 11” for bleed

Paper Stock: Text Pages: 45# coated.

Covers: 100# coated.

Type of Binding: Perfect bound.

Ad Size (inches) Trim Sizes (Width x Depth)

Bleed Sizes (Width x Depth)

Live area (Width x Depth)

1 Page 7.75 x 10.75 8 x 11 7 x 10

2/3 Page Vertical 5 x 10.75 5.25 x 11 4.25 x 10

1/2 Page Horizontal 7.75 x 5.40 8 x 5.625 7 x 4.625

1/2 Page Vertical 3.875 x 10.75 4.125 x 11 3.125 x 10

1/3 Page Vertical 2.50 x 10.75 2.75 x 11 1.75 x 10

AD SIZES (IN INCHES)

PRACTICAL, PEER-REVIEWED PERSPECTIVES SINCE 1987

OCTOBER 2018 | Vol 32 • No 10

How an Expert Approaches itProstate Cancer: When to Order an MRIAnnerleim Walton-Diaz, MD, Soroush Rais-Bahrami, MD

Genomics in PracticeEGFR-Mutated Lung CancerEmily Wynja, MSIV, Jenna Hove, BSN, Steven F. Powell, MD

Review ArticleImmunotherapy in Colorectal CancerCara Wilt, CRNP, Dung T. Le, MD

CAREY ANDERS ON

Dual HER2 Targeting in theAdjuvant Setting‘We must consider the financial toxicities’

OCTOBER 2018 VOL. 32 NO. 10

D

UA

L HE

R2

TAR

GE

TIN

G • H

ER

B-D

RU

G IN

TE

RA

CT

ION

S • P

SY

CH

OS

OC

IAL D

IST

RE

SS

• CD

K4

/6 IN

HIB

ITO

RS

C

AN

CE

RN

ET

WO

RK

.CO

M

Hemotology............................................. 817 Internal Medicine ................................. 4,860 Hemotology and Oncology ................. 9,931 Oncology, Medical ............................... 3,508 Gastroenterology ........................................ 1 Gynecological Oncology ........................ 808 Pediatrics, Hemotology - Oncology ........... 4 Radiation Oncology ............................. 4,831 Surgery, Colon & Rectal ........................... 54 Surgery, General ......................................... 6 Urology ................................................. 2,304 Other Professional Classifications ....... 1,076

Total Copies To Physicians ������������������������� 28,200

Print Circulation

Specialty Total

*As filed with the BPA, subject to audit.

Page 6: 2019 media kitmmhimages.com/mkt/hc/mk/oncology_mk_2019_print.pdf2019 media kit 28K+ Print Circulation 8.00 Mins. Pages per Time on Site* 33.8K US E-News subscribers 161.4K Unique Visitors*

CancerNetwork.comLast revised: 12/11/2018and

PRINT DISPLAY ADVERTISING RATES – FULL-RUN:

Color: In addition to earned B&W rates. Charge per color/page or fraction

Second Color (magenta, cyan, yellow): ..................................................................................................................... $600 Matched Color (all PMS excluding 800 series): ........................................................................................................... $890 Sheen/Metallic/Fluorescent color (PMS 800 series): .................................................................................................$1,260 3- and 4-color process: .......................................................................................................................................... $2,045 5-color: .................................................................................................................................................................. $2,595

Covers and Premium Positions (non-cancelable)*:Add the premium for positions to the earned B&W rate. Then add charge for color.

Cover Rates: Second cover: 25% | Fourth cover**: 50%

Premium Positions: ONCOLOGY Table of Contents: 10% | Cancer Network Table of Contents: 10%

Special Position Charge: A 5% per page special position charge is incurred when requesting consecutive right-hand pages or other special positioning.

*Does not include 4C process charges. When a cover is included in a multiple-page space unit, all pages must be in full pages.

Cover Tips/Outserts:Consult publisher for rates and availability.

Cancellation Policy with Letter of Agreement:

60 days or more prior to issue ad close deadline, no charge.

30–60 days prior to issue ad close deadline, 50% of contract rate.

30 days or less prior to issue ad close deadline, 100% of contract rate.

Demographic Rates:ROB ads available on a limited basis. Rates for demographic ads are calculated by multiplying the percent of circulation requested (minimum 50%) times the one-time B&W page rate, times the total number of pages, plus applicable color rates at full price, plus a $1,650 (non-commissionable) mechanical charge. Demographic ads will count toward a company’s final earned frequency on a page-for-page basis.

print rates

INSERT ADVERTISING RATES – FULL-RUN: Insert Rates 1x 6x 12x 24x 36x 48x 60x 72x 96x 120x 144x 168x 192x 216x 264x 312x 360x

2 page insert $9,190 $9,050 $8,940 $8,820 $8,520 $8,400 $8,280 $8,160 $8,050 $7,920 $7,700 $7,590 $7,460 $7,340 $7,220 $7,110 $6,990

4 page insert 18,380 18,100 17,880 17,640 17,040 16,800 16,560 16,320 16,100 15,840 15,400 15,180 14,920 14,680 14,440 14,220 13,980

6 page insert 27,150 26,820 26,460 25,560 25,200 24,8t40 24,480 24,150 23,760 23,100 22,770 22,380 22,020 21,660 21,330 20,970

8 page insert 36,200 35,760 35,280 34,080 33,600 33,120 32,640 32,200 31,680 30,800 30,360 29,840 29,360 28,880 28,440 27,960

B&W rates 1x 6x 12x 24x 36x 48x 60x 72x 96x 120x 144x 168x 192x 216x 264x 312x 360x

Full page $4,595 $4,525 $4,470 $4,410 $4,260 $4,200 $4,140 $4,080 $4,025 $3,960 $3,850 $3,795 $3,730 $3,670 $3,610 $3,555 $3,495

2/3 page 3,770 3,720 3,665 3,615 3,500 3,450 3,395 3,345 3,295 3,240 3,165 3,110 3,065 3,015 2,965 2,890 2,835

1/2 page 3,100 3,055 3,015 2,975 2,875 2,835 2,795 2,760 2,715 2,665 2,600 2,560 2,515 2,475 2,415 2,365 2,300

1/3 page 2,600 2,580 2,570 2,540 2,450 2,420 2,380 2,350 2,310 2,270 2,220 2,180 2,145 2,110 2,080 2,040 2,010

Acceptance: Insert stock weight 80 # text. Contact publisher for approval and pricing for inserts heavier than 80 # text. Submit samples to Production Manager.

Demographic Rates: Inserts available on a limited basis. Rates for demographic inserts are calculated by multiplying the percent of circulation requested (minimum 50%) times the one-time B&W

page rate, times the total number of pages, plus a $1,450 (non-commissionable) mechanical charge. Demographic ads will count toward a company’s final earned frequency on a page-for-page basis.

Page 7: 2019 media kitmmhimages.com/mkt/hc/mk/oncology_mk_2019_print.pdf2019 media kit 28K+ Print Circulation 8.00 Mins. Pages per Time on Site* 33.8K US E-News subscribers 161.4K Unique Visitors*

CancerNetwork.comLast revised: 12/11/2018and

discount information

CORPORATE DISCOUNTSEarned Rates: Earned rates are given to advertisers based on advertising frequency within a 12-month period. The earned rate is determined by the number of insertions. A spread counts as two insertions. Full pages and fractional pages count as single insertions. Demographic ads will count toward a company’s final earned frequency on a pro-rated basis (e.g., a 4-page unit going to 50% of circulation = 2X). Insertions from a parent company and its subsidiaries are combined to determine earned rate. Advertisers are short-rated or rebated based on year end final level earned. The minimum number of insertions at each level must be met within the 2019 calendar or fiscal year.

Corporate Discount Program: Effective with January 1, 2019 insertion orders, the Corporate Discount program is based on an advertiser’s 2018 net advertising, including digital spending, plus non-CME promotional project expenditures in all of the UBM Medica media. Please contact your account manager for more information and your discount rate.

2018 NetCorporate Spend Rate Savings 2018 Net

Corporate Spend Rate Savings

$100,000 - $250,000 0.50% $2,500,001 - $3,000,000 5.00%$250,001 - $500,000 0.75% $3,000,001 - $3,500,000 6.00%

$500,001 - $750,000 1.00% $3,500,001 - $4,000,000 8.00%

$750,001 - $1,000,000 1.50% $4,000,001 - $4,500,000 10.00%

$1,000,001 - $1,500,000 2.00% $4,500,001 - $5,000,000 12.00%

$1,500,001 - $2,000,000 3.00% $5,000,001 - $5,500,000 14.00%

$2,000,001 - $2,500,000 4.00% $5,500,001 - $6,000,000 16.00%

Pre-Payment: Prepayment discounts are offered to advertisers; please contact Group Publisher for details.

Multiple Page PI Discount: Ads running more than two pages of prescribing information are offered a discount. Starting with the third PI page of the unit, a 50% discount will be applied to the cost of the page.

ADVERTISING INCENTIVE DISCOUNTSProduct Incentive Program (PIP Continuity Discount): Run a minimum of three product insertions in ONCOLOGY and save. The more insertions, the more you save. Free pages count toward earned frequency but do not count toward the corporate discount program.

Product Incentive Program Criteria:

i) The minimum number of insertions at each level must be met within a calendar or fiscal year.

ii) For simplicity, and maximum savings, the Product Incentive Program percent savings will be taken off the product’s gross insertion expenditure. The PIP discount should be added to your corporation’s Corporate Discount Program earned discount, and the resulting total percentage is taken off of the gross insertion cost.

iii) You can project what Product Incentive Program level you will achieve for the year and begin to realize savings immediately. At your earliest convenience, please notify your ONCOLOGY account manager of your product’s planned Product Incentive Program participation level. If the product does not meet the projected level, or exceeds its projected level, that product will be short rated or rebated accordingly. If the product is pulled off the market due to an FDA ruling, the accrued savings will stand, and the company will not be penalized for loss of product continuity.

iv) All of a product’s indications work together to attain a product’s insertion level.

ABC (Add A Book Combo): When you advertise in ONCOLOGY and run the same product in the same month in another UBM Medica medical publication(s) (i.e., Contemporary OB/GYN, Contemporary Pediatrics, Dermatology Times, Drug Topics, Managed Healthcare Executive, Medical Economics, Psychiatric Times and Urology Times), you will receive a discount dependent upon the number of publications you run in. The more titles you choose, the deeper the discount.

2 publication buy = 10% 3 publication buy = 15% 4+ publication buy = 20%

Note: This discount applies to full run ads only and may not be used when advertising in Ophthalmology Times, Ophthalmology Times Europe, Optometry Times, Dental Products Report, and The Aesthetics Guide. This discount cannot be used in combination with the Product Incentive Plan (PIP) but may be used with the Corporate Discount Program. This discount applies to the nine UBM Medica publications shown only and may be used in any combination. For products with different size ad units, the discount will be calculated based on the mutual number of pages. For example, if 6 pages run in one publication and 4 pages run in the other, under this program, the discount will be applied to the 4 matching pages in each magazine. Free runs do not count toward the discount.

Launch Incentive: Run in four consecutive issues and the 5th issue is free. This discount applies to new products, new indications and new formulations of existing products. Free ads must be the same size or smaller, and pre-launch ads do not count toward the launch discount. The Launch discount and the PIP program discount cannot be taken at the same time -- PIP goes into effect after the 4th issue. Free pages count toward earned frequency but do not count toward the corporate discount program.

Number of Insertions: 3x 6x 9x 12x

Discount: 2% 3% 4% 5%

Page 8: 2019 media kitmmhimages.com/mkt/hc/mk/oncology_mk_2019_print.pdf2019 media kit 28K+ Print Circulation 8.00 Mins. Pages per Time on Site* 33.8K US E-News subscribers 161.4K Unique Visitors*

CancerNetwork.comLast revised: 12/11/2018and

SCREEN REQUIREMENTS Density of Tone: 4C ads not exceed 300%; 2C, 190%; B&W, 95%.

1� CMYK is the only accepted mode for 4C ads. Do not use RGB.

2� Do not use spot color unless you are paying for a PMS (Pantone) color.3� Colors viewed on your monitor may not be representative

of final output.Always check monitor color values against CMYK color swatches and the final KODAK APPROVAL color proof or equivalent. Laser color proofs are for identification only. Should proofs not meet specifications, we will print to published SWOP ink densities. [email protected], [email protected], [email protected], and [email protected].

REPRODUCTION REQUIREMENTS: Follow “Specifications for Web Offset Publication” (SWOP) Tenth Edition for printing in the new millennium. ONCOLOGY is printed Web offset. Our preferred ad page material is an electronic digital file furnished as a PDF/X1a. Any omissions, or color deviation from a submitted proof, other than a quality KODAK APPROVAL or equivalent, will not warrant adjustment for space or color charge.

DISPOSITION OF MATERIAL AND INSERTS: Electronic ad files are held for one year from date of last insertion. Supplied inserts/outserts spoilage will be automatically recycled unless otherwise requested in advance.

DIGITAL AD REQUIREMENTS:1� Digital data is required for all ad submissions. Preferred format is PDF/X-

1a. Note that a standard PDF is not a preferred format, files should be a PDF/X-1a which is a PDF subset specific to printing. Publisher shall have no obligation or liability to Advertiser of any kind (including, without limitation, the obligation to offer Advertiser makegoods or any other form of compensation) if an ad is supplied to Publisher by Advertiser in any format other than our preferred formats. Non-preferred or non-acceptable formats will be charged a $150 processing fee. All files should be built to exact ad space dimensions purchased. For detailed instructions on preparing PDF/X-1a files and submitting ad files to the correct size, go to www.ubmmedica.com or contact the production manager.

2� Publisher will not supply a faxed or soft proof for Advertiser-supplied files. Advertiser is solely responsible for preflighting and proofing all advertisements prior to submission to Publisher. If Publisher detects

an error before going to press, Publisher will make a reasonable effort to contact Advertiser to give Advertiser an opportunity to correct and resubmit Advertiser’s file before publication.

3� Accepted Method of Delivery: The file format must be PDF/X-1a. You may submit digital ad files via the Ad Portal: https://ads.ubm.com.

4� Ad Proofs: To insure that Advertiser’s ad is reproduced correctly, a SWOP-certified color proof that has been made from the same file that Advertiser supplies to Publisher must be provided. Publisher cannot provide Advertiser any assurances regarding the accuracy of reproduction of any ad submitted without a SWOP proof. Publisher shall have no obligation or liability to Advertiser of any kind (including, without limitation, the obligation to offer Advertiser makegoods or any other form of compensation) for any ad supplied to Publisher by Advertiser without a SWOP proof.

PROVIDER INFORMATION REQUIRED: 1� Issue date. 2� Advertiser, product, and agency name. 3� Agency contact person and phone number,

or vendor name and phone number.4� List of contents.

PRINT PRODUCTION MATERIALS: Email Insertion orders, contracts and other instructions to: [email protected] with a copy to [email protected].

Send all non-eMailed print materials and other information to:

ONCOLOGY Karen Lenzen Media Operations Manager – UBM Americas 131 W. First St. Duluth, MN 55802 Ph: 218-740-7271 [email protected]

To submit your ad materials, visit https://ads.ubm.com

print specifications and display ad requirements

COVER TIPSTrimming: Live matter: 6-1/2” x 4-1/2”Trim size: 7” x 5”Bleed size: 7-1/4” x 5-1/4”Digital File Requirements: PDF/X-1a, set resolution 300 dpi or higherCover tips jog to the bottom, glue along spine�

If client supplies, please provide at trim size 7”x 5”, 80# stock without attachments

For anything not matching the specs on cover tips and inserts above, please contact the publisher for special pricing AND send sample for pre-approval to:

ONCOLOGY Karen Lenzen Media Operations Manager – UBM Americas 131 W. First St. Duluth, MN 55802 Ph: 218-740-7271 [email protected]

INSERTSTrimming: Ship folded: 8” x 11” Keep live matter 1/2” from trimmed edges & 1/2” from gutter trim Book is jogged to head Trims: 1⁄8” head, allow 1⁄8” for gutter, outside, and foot trim

Quantity: Full Run: 35,000

Shipping: Mark all insert cartons with publication name, date of issue, advertiser, product name, and insert quantity. Include a sample of the insert, identifying front/back or page numbers, and attach this sample to the outside of cartons.

ONCOLOGY (Month of Issue) c/o LSC Communications Attn: Jeremiah Jay 3401 Heartland Drive Liberty, MO 64068

Page 9: 2019 media kitmmhimages.com/mkt/hc/mk/oncology_mk_2019_print.pdf2019 media kit 28K+ Print Circulation 8.00 Mins. Pages per Time on Site* 33.8K US E-News subscribers 161.4K Unique Visitors*

CancerNetwork.comLast revised: 12/11/2018and

JANUARY ISSUE FEBRUARY ISSUE MARCH ISSUE

APRIL ISSUE MAY ISSUE JUNE ISSUE

production and editorial calendar 2019

» Ad close: December 20 » Materials due: December 28 » Inserts due: January 02

» Ad close: January 22 » Materials due: January 28 » Inserts due: January 30

» Ad close: February 19 » Materials due: February 25 » Inserts due: February 27

» Ad close: March 19 » Materials due: March 25 » Inserts due: March 27

» Ad close: April 15 » Materials due: April 19 » Inserts due: April 23

» Ad close: May 22 » Materials due: May 29 » Inserts due: May 31

• New research in blood cancer treatments• Cancer prevention• Prostate cancer

• Colorectal cancer• Non-Hodgkin lymphoma (NHL)• Cardiac health and cancer treatment

• Testicular cancer• Esophageal cancer• Stem cell transplantation

Bonus Distribution: American Society of Clinical Oncology (ASCO) Annual Meeting, May 31-June 4, Chicago, IL

• Myeloma• Bladder cancer• Melanoma

Bonus Distribution: American Society of Clinical Oncology (ASCO) Annual Meeting, May 31-June 4, Chicago, IL

• Hodgkin’s lymphoma• The state of cancer research• Survivorship

• Acute myelogenous leukemia (AML)• Stomach cancer• Sarcoma

Page 10: 2019 media kitmmhimages.com/mkt/hc/mk/oncology_mk_2019_print.pdf2019 media kit 28K+ Print Circulation 8.00 Mins. Pages per Time on Site* 33.8K US E-News subscribers 161.4K Unique Visitors*

CancerNetwork.comLast revised: 12/11/2018and

JULY ISSUE AUGUST ISSUE SEPTEMBER ISSUE

OCTOBER ISSUE NOVEMBER ISSUE DECEMBER ISSUE

» Ad close: June 17 » Materials due: June 21 » Inserts due: June 25

» Ad close: July 23 » Materials due: July 29 » Inserts due: July 31

» Ad close: August 19 » Materials due: August 23 » Inserts due: August 27

» Ad close: September 16 » Materials due: September 20 » Inserts due: September 24

» Ad close: October 22 » Materials due: October 28 » Inserts due: October 30

» Ad close: November 15 » Materials due: November 21 » Inserts due: November 25

• Acute lymphocytic leukemia (ALL)• Lung Cancer• Ovarian cancer

• Novel Therapeutic Strategies in Pediatric --- Hematological Malignancies

• Thyroid cancer• Breast Cancer

• Chronic lymphocytic leukemia (CLL)• Liver cancer• Endometrial cancer

• Myelodysplastic syndromes (MDS)• Lung cancer• Neuroendocrine tumors

Bonus distribution: ASH Annual Meeting and Exposition, December 7-10, Orlando, FL

• Chronic myelogenous leukemia (CML)• Pancreatic cancer• Immunotherapy

• Myeloproliferative neoplasms (MPNs) • Cervical cancer• Kidney cancer

production and editorial calendar 2019

Page 11: 2019 media kitmmhimages.com/mkt/hc/mk/oncology_mk_2019_print.pdf2019 media kit 28K+ Print Circulation 8.00 Mins. Pages per Time on Site* 33.8K US E-News subscribers 161.4K Unique Visitors*

CancerNetwork.comLast revised: 12/11/2018and

We know healthcare. We get results.We partner with our clients to deliver strategic, integrated communications solutions to key decision-makers through the proven strength of our brands, when and where our clients need it.

contact information

PRACTICAL, PEER-REVIEWED PERSPECTIVESOncologyubmmedica.com/markets-products/oncology